Neuroscientists have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and FTD in mice -- and may even offer the potential to reverse some of the effects of the fatal diseases. It may also hold opportunities for treating more common forms of dementia, such as Alzheimer's disease.
